Skip to main content
TipRanks
Go Ultimate75% OFF

Novo Nordisk (NVON) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
DenecimigHaemophilia APhase IIIRecruitingA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia ASep 15, 2026―
CagrisemaDiabetes Mellitus, Type 2Phase IIIRecruitingResearch Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaSep 08, 2026
Zenagamtide Injection, Zenagamtide TabletObesity, OverweightPhase IRecruitingA Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or ObesitySep 06, 2026
Nnc0705-0002Healthy Volunteers, Cardiometabolic DiseasesPhase IRecruitingA Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy PeopleAug 27, 2026
SemaglutideObesity, OverweightPhase IIIRecruitingResearch Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightAug 13, 2026
Semaglutide, Nnc0721-8060Obesity, OverweightPhase IRecruitingA First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or ObesityAug 11, 2026
Nnc0487-0111, LedObesity, OverweightPhase IRecruitingA Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or PlaceboJul 30, 2026
CagrilintideObesity, OverweightPhase IIIRecruitingA Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body WeightJul 30, 2026
ZenagamtideObesity, OverweightPhase IIINot Yet RecruitingAMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose WeightJul 17, 2026
Nnc6022-0004Obesity, Elevated High-Sensitivity C-Reactive Protein (Hscrp)Phase IRecruitingA Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With ObesityJul 03, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Novo Nordisk (MX:NVON) have in its pipeline
Novo Nordisk MX:NVON is currently developing the following drugs: Denecimig, Cagrisema, Zenagamtide Injection, Zenagamtide Tablet, Nnc0705-0002, Semaglutide, Semaglutide, Nnc0721-8060, Nnc0487-0111, Led, Cagrilintide, Zenagamtide, Nnc6022-0004, Semaglutide, Ubt251, Semaglutide, Zenagamtide, Semaglutide, Nnc0662-0419, Cagrilintide B, Cagrilintide D, Nnc0497-0040, Nnc0487-0111, Nnc0113-5840, Semaglutide, Cagrisema, Cagrilintide D, Oral Contraceptive, Acetaminophen, Nnc0662-0419, Nnc6989-0001 A, Semaglutide, Nnc0487-0111, Ubt251, Nnc0363-1063, Ziltivekimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.